
Cotrimoxazole tablets
Form: Tablets
Strength: 80 mg trimethoprim / 400 mg sulfamethoxazole
Reference Brands: Bactrim, Septra(US & EU)
Category: Transplant
Cotrimoxazole tablets, marketed as Bactrim and Septra, are approved in the US by the FDA and in the EU via EMA for treating bacterial infections including urinary tract, respiratory, and skin infections. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and worldwide availability of cotrimoxazole tablets, ensuring effective antibacterial therapy for patients across the globe.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Acyclovir tablet
Strength: 200 mg, 400 mg, 800 mg
Form: Tablets
Reference Brands: Zovirax(US & EU)
View Details Get EnquiryBelatacept injection
Strength: 250 mg/vial
Form: Injection
Reference Brands: Nulojix(US)
View Details Get EnquiryBasiliximab Injectable Solution
Strength: 20 mg/vial
Form: Injectable Solution
Reference Brands: Simulect(US)
View Details Get EnquiryPrednisolone syrup
Strength: 15 mg/5ml
Form: Syrup
Reference Brands: Orapred(US)
View Details Get Enquiry